PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 73 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,179 | +86026.9% | 225,432 | +182.2% | 0.00% | – |
| Q1 2023 | $78 | -86.5% | 79,873 | -85.6% | 0.00% | – |
| Q4 2022 | $577 | -99.7% | 554,918 | +259.3% | 0.00% | – |
| Q3 2022 | $178,000 | -64.6% | 154,434 | -42.6% | 0.00% | – |
| Q2 2022 | $503,000 | -76.7% | 269,074 | -62.2% | 0.00% | -100.0% |
| Q1 2022 | $2,157,000 | -53.5% | 711,923 | -42.0% | 0.00% | -50.0% |
| Q4 2021 | $4,640,000 | -56.2% | 1,227,581 | -40.0% | 0.00% | -66.7% |
| Q3 2021 | $10,582,000 | -6.4% | 2,046,850 | -30.7% | 0.01% | -14.3% |
| Q2 2021 | $11,309,000 | +4712.3% | 2,952,631 | +3047.4% | 0.01% | – |
| Q4 2020 | $235,000 | +47.8% | 93,812 | +21.8% | 0.00% | – |
| Q3 2020 | $159,000 | -40.9% | 77,021 | -11.3% | 0.00% | – |
| Q2 2020 | $269,000 | +572.5% | 86,869 | +690.5% | 0.00% | – |
| Q4 2019 | $40,000 | -68.3% | 10,989 | -70.3% | 0.00% | – |
| Q3 2019 | $126,000 | -97.8% | 36,970 | -97.0% | 0.00% | -100.0% |
| Q2 2019 | $5,703,000 | +202.2% | 1,213,461 | +115.5% | 0.01% | +200.0% |
| Q1 2019 | $1,887,000 | -22.9% | 563,199 | -38.8% | 0.00% | -25.0% |
| Q4 2018 | $2,446,000 | -74.4% | 919,582 | -46.0% | 0.00% | -66.7% |
| Q3 2018 | $9,539,000 | +74.0% | 1,703,380 | +57.5% | 0.01% | +71.4% |
| Q2 2018 | $5,483,000 | -55.9% | 1,081,470 | -40.7% | 0.01% | -58.8% |
| Q1 2018 | $12,440,000 | +135.5% | 1,824,109 | +160.7% | 0.02% | +142.9% |
| Q4 2017 | $5,283,000 | +106.9% | 699,771 | +57.9% | 0.01% | +75.0% |
| Q3 2017 | $2,553,000 | +113.5% | 443,149 | +87.5% | 0.00% | +100.0% |
| Q2 2017 | $1,196,000 | +3524.2% | 236,307 | +1198.0% | 0.00% | – |
| Q3 2016 | $33,000 | +57.1% | 18,205 | +39.0% | 0.00% | – |
| Q2 2016 | $21,000 | -81.4% | 13,097 | -78.0% | 0.00% | – |
| Q1 2016 | $113,000 | -69.0% | 59,608 | -62.6% | 0.00% | -100.0% |
| Q4 2015 | $365,000 | – | 159,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |